Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Interferon Levels Explain mRNA Vaccine Side Effects

Analysis based on 6 articles · First reported Sep 17, 2026 · Last updated Sep 20, 2026

Sentiment
5
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study is a scientific advance that could inform future vaccine design, potentially benefiting vaccine developers such as Moderna by supporting next-generation products with improved tolerability. Near-term market impact is minimal as the findings do not change current vaccine efficacy or regulatory status.

pharmaceuticals biotechnology healthcare

Researchers from the University of Geneva and Geneva University Hospitals published a study in Science Translational Medicine identifying why some people experience stronger side effects after mRNA COVID-19 vaccination. The team monitored 51 healthy individuals who received two doses of an mRNA vaccine and found that those with a more active innate interferon response before vaccination were more likely to develop transient symptoms such as fever, fatigue, and injection-site pain. A second mechanism was identified in an animal model, where acquired immunity after a first dose amplified activation of innate immune cells, notably monocytes, upon subsequent doses. Study leader Arnaud Didierlaurent emphasized that side effect severity is not an indicator of vaccine effectiveness. First author Natacha Madelon noted the role of the interferon-related antiviral defense system. The research was supported by the HUG Private Foundation, the Giorgio Cavaglieri Foundation, and Moderna. The findings could eventually help develop better-tolerated vaccines, and the team plans to investigate whether similar mechanisms apply to other vaccine types.

60 Geneva University Hospitals published study
40 Moderna funded research
per
Associate Professor and study leader who directed the research and highlighted that side effect severity does not indicate vaccine effectiveness.
Importance 85.0 Sentiment 5.0
priv
Co-led the study and recruited the 51 healthy participants, reinforcing its role as a clinical research center.
Importance 80.0 Sentiment 5.0
per
First author of the study who explained the role of the interferon-related antiviral defense system in individual side effect differences.
Importance 70.0 Sentiment 5.0
stock
Partially funded the research on its mRNA vaccine platform; findings could support development of better-tolerated mRNA vaccines, a modest positive for its long-term product pipeline.
Importance 40.0 Sentiment 10.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.